A multicenter phase I-II trial of weekly paclitaxel and carboplatin plus bevacizumab in women with triple-negative metastatic breast cancer.
Emmanouil S. Saloustros
No relevant relationships to disclose
Aristidis Polyzos
No relevant relationships to disclose
Charalampos Christophyllakis
No relevant relationships to disclose
Nikolaos K. Kentepozidis
No relevant relationships to disclose
Lampros Vamvakas
No relevant relationships to disclose
Kostas Kalbakis
No relevant relationships to disclose
Sofia Agelaki
No relevant relationships to disclose
Vassilis Georgoulias
No relevant relationships to disclose
Dimitrios Mavroudis
No relevant relationships to disclose